Your browser doesn't support javascript.
loading
Validating a Selective S1P1 Receptor Modulator Syl930 for Psoriasis Treatment.
Ji, Ming; Xue, Nina; Lai, Fangfang; Zhang, Xiaoying; Zhang, Sen; Wang, Yuchen; Jin, Jing; Chen, Xiaoguang.
Afiliação
  • Ji M; State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College.
  • Xue N; Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College.
  • Lai F; State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College.
  • Zhang X; State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College.
  • Zhang S; State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College.
  • Wang Y; Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College.
  • Jin J; Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College.
  • Chen X; State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College.
Biol Pharm Bull ; 41(4): 592-596, 2018 Apr 01.
Article em En | MEDLINE | ID: mdl-29415945

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxazóis / Propanolaminas / Psoríase / Pele / Anti-Inflamatórios não Esteroides / Receptores de Lisoesfingolipídeo / Modelos Animais de Doenças Tipo de estudo: Prognostic_studies Idioma: En Revista: Biol Pharm Bull Assunto da revista: BIOQUIMICA / FARMACOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de publicação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxazóis / Propanolaminas / Psoríase / Pele / Anti-Inflamatórios não Esteroides / Receptores de Lisoesfingolipídeo / Modelos Animais de Doenças Tipo de estudo: Prognostic_studies Idioma: En Revista: Biol Pharm Bull Assunto da revista: BIOQUIMICA / FARMACOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de publicação: Japão